PALEKAR ROHAN

CIK 00014233274 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001423327

Recent Transactions

50 trades

Award
Neurogene Inc.$NGNE
Non-Qualified Stock Option (right to buy)
2026-02-20+12,050→ 12,050 total
Disposition from Tender
89bio, Inc.$ETNB
Common Stock
2025-10-30−934,273→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−120,231→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−220,000→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−203,750→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−300,000→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−848,000→ 0 total
Award
89bio, Inc.$ETNB
Common Stock
2025-10-30+125,000→ 934,273 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−132,242→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−170,000→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−605,000→ 0 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2025-08-01$9.16/sh−55,836→ 808,070 total
Award
Neurogene Inc.$NGNE
Non-Qualified Stock Option (right to buy)
2025-06-12+12,050→ 12,050 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2025-02-17$10.57/sh−3,249→ 862,240 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2025-02-09$11.41/sh−8,946→ 864,692 total
Award
89bio, Inc.$ETNB
Common Stock
2025-02-01+212,000→ 683,236 total
Award
89bio, Inc.$ETNB
Common Stock
2025-02-01+200,000→ 883,236 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2025-02-01$9.60/sh−9,598→ 873,638 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-02-01+848,000→ 848,000 total
Purchase
89bio, Inc.$ETNB
Common Stock
2024-12-06$7.89/sh+5,000→ 471,236 total
Purchase
89bio, Inc.$ETNB
Common Stock
2024-11-22$8.35/sh+10,000→ 466,236 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2024-08-17$8.04/sh−4,601→ 456,236 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2024-06-14+7,700→ 7,700 total
Exercise/Conversion
89bio, Inc.$ETNB
Common Stock
2024-04-01$1.93/sh+25,000→ 511,889 total
Exercise/Conversion
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2024-04-01−25,000→ 120,231 total
Sale
89bio, Inc.$ETNB
Common Stock
2024-04-01$10.91/sh−52,718→ 459,171 total
Sale
89bio, Inc.$ETNB
Common Stock
2024-02-26$10.76/sh−4,477→ 486,889 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2024-02-17$9.74/sh−4,602→ 491,366 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2024-02-09$8.45/sh−12,670→ 480,968 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2024-02-05$9.80/sh−5,068→ 493,646 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2024-02-01+605,000→ 605,000 total
Award
89bio, Inc.$ETNB
Common Stock
2024-02-01+150,000→ 498,714 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2024-01-16+15,400→ 15,400 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2024-01-05$11.53/sh−27,511→ 348,714 total
Award
89bio, Inc.$ETNB
Common Stock
2024-01-05+75,000→ 376,225 total
Sale
89bio, Inc.$ETNB
Common Stock
2023-12-29$11.20/sh−50,000→ 301,225 total
Exercise/Conversion
89bio, Inc.$ETNB
Common Stock
2023-12-29$1.93/sh+50,000→ 351,225 total
Exercise/Conversion
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2023-12-29−50,000→ 145,231 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2023-08-17$15.46/sh−4,501→ 300,950 total
Award
89bio, Inc.$ETNB
Common Stock
2023-06-30+33,334→ 321,978 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2023-06-30$18.95/sh−16,527→ 305,451 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2023-06-08+25,000→ 25,000 total
Exercise/Conversion
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2023-06-05−15,000→ 195,231 total
Sale
89bio, Inc.$ETNB
Common Stock
2023-06-05$20.00/sh−15,000→ 286,978 total
Exercise/Conversion
89bio, Inc.$ETNB
Common Stock
2023-06-05$1.93/sh+15,000→ 301,978 total
Award
89bio, Inc.$ETNB
Common Stock
2023-03-31+33,333→ 302,413 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2023-03-31$15.23/sh−15,443→ 286,970 total
Sale
89bio, Inc.$ETNB
Common Stock
2023-03-23$16.00/sh−15,000→ 269,080 total
Tax Payment
89bio, Inc.$ETNB
Common Stock
2023-02-17$13.97/sh−6,279→ 284,072 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2023-02-09+300,000→ 300,000 total

Companies

Recent Filings

Address

C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR

NEW YORK, NY, 10011

View on SEC.gov